Black Cohosh Appears Safe for Menopausal Breast Cancer Patients

October 4, 2002

1 Min Read
SupplySide Supplement Journal logo in a gray background | SupplySide Supplement Journal

SALZGITTER, Germany--It appears that black cohosh may be a safe alternative for menopausal women who have breast cancer. Researchers from Schaper & Brummer GmbH & Co. KG, maker of the supplement RemiFemin®, investigated black cohosh's (Cimicifuga racemosa) effects on estrogen-dependent mammary cancers in vitro, results of which are reported in the November edition of Breast Cancer Research and Treatment (76, 1:1-10, 2002).

It was found that black cohosh significantly inhibited MCF-7 (breast cancer tumor) cell proliferation, as well as estrogen-induced proliferation of MCF-7 cells. Moreover, the chemopreventive drug tamoxifen's effect of inhibiting MCF-7 proliferation was also enhanced by black cohosh.

The researchers, led by Johannes Freudenstein, Ph.D., concluded that black cohosh's non-estrogenic, even estrogen-antagonistic effect, may make this herb a safe, natural remedy for menopausal symptoms experienced by breast cancer patients.

The study can be found here.

Subscribe for the latest consumer trends, trade news, nutrition science and regulatory updates in the supplement industry!
Join 37,000+ members. Yes, it's completely free.

You May Also Like